Led by BioN­Tech, six biotechs line up for Oc­to­ber IPOs

Oc­to­ber: The sea­son of swirling red leaves, Jack-o-lanterns, post­sea­son base­ball and this year, a fresh har­vest of six biotech IPOs ripe with clin­i­cal-stage drugs, try­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER